US equities |
MU $906.00 ▼-0.89% NVDA $217.05 ▼-1.92% SNDK $1,348.57 ▼-3.90% SPCX $146.85 ▼-3.49% AMD $551.86 ▼-3.32% INTC $93.91 ▼-4.29% AAPL $342.53 ▼-0.13% TSM $418.95 ▼-2.57%
FinancialContent

Ludwig Enterprises Inc (OP:LUDG)

0.0049 UNCHANGED
Delayed Quote Updated: 1:37 PM EDT, Oct 13, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Ludwig Enterprises Inc

< Previous 1 2 Next >
News headline image
Ludwig Enterprises Announces Publication of ASCO Abstract Detailing Novel Non-Invasive mRNA Signals that Scan for Breast Cancer
Via ACCESS Newswire
News headline image
Revealia Breast(TM) Offers Glimpse Into the Future of Early Cancer Detection With a Simple Cheek Swab
Via ACCESS Newswire
News headline image
Ludwig Enterprises Announces Two Abstracts Accepted for Publication in the Journal of Clinical Oncology
Via ACCESS Newswire
News headline image
Ludwig Enterprises Inc. Announces New Leadership Appointment of Charles T. Todd, Jr.
Via ACCESS Newswire
News headline image
Ludwig Enterprises Begins PCR Validation Test Process
Via ACCESSWIRE
News headline image
Ludwig Enterprises Files Provisional Patent for Revolutionary Cancer Screening Algorithm, Plans 2024 Launch as Revealia(TM)
Via ACCESSWIRE
News headline image
CORRECTING AND REPLACING: Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology
Via ACCESSWIRE
News headline image
Ludwig Enterprises Inc. Announces AI-Powered Cancer Screening Technology
Via ACCESSWIRE
News headline image
Ludwig Announces Acquisition of Intellectual Property and Patent
Via ACCESSWIRE
News headline image
Ludwig Announces Substantial Corporate Initiatives
Via ACCESSWIRE
News headline image
Ludwig Enterprises Files Provisional Patent on mRNA Genetic Screening Signals in Breast, Colon and Bladder Cancer
Via ACCESSWIRE
News headline image
Ludwig Enterprises Inc (OTC:LUDG) Funds Incurable Brain Cancer Study
Via ACCESSWIRE
News headline image
Ludwig Enterprises mRNA Bladder Cancer Study to be Launched
Via ACCESSWIRE
News headline image
Ludwig Enterprises, Inc. Announces Marvin S. Hausman, M.D. as Chief Executive Officer
Via ACCESSWIRE
News headline image
LUDG Files Genomic Patent AI Uncovers Differentially Expressed Genes
Via ACCESSWIRE
News headline image
Exousia AI Ludwig Enterprises Subsidiary Launches Liposome Research Program
Via ACCESSWIRE
News headline image
Ludwig Enterprises Appoints Scott Silverman as CFO
Via ACCESSWIRE
News headline image
Ludwig Enterprises Announces Effectiveness of Form S-1 Registration Application, Becomes an SEC Reporting Company
Via ACCESSWIRE
News headline image
Ludwig Enterprises to Launch New Nutraceutical in Hair Loss Market
Via ACCESSWIRE
News headline image
Ludwig Enterprises Announces Launch of New Nutraceutical and Strategic Marketing Plan
Via ACCESSWIRE
News headline image
Ludwig Enterprises Launches NuGenea, Groundbreaking Nutraceutical to Fight Inflammation
Via ACCESSWIRE
News headline image
Decoding mRNA for Early Disease Detection, Treatment & Prevention
Via ACCESSWIRE
News headline image
Ludwig Enterprises Announces Agreement with Summit Bancorp to Assist with Cross Listing on the Canadian Stock Exchange
Via ACCESSWIRE
News headline image
Ludwig Enterprises Announces Intention to List on the Canadian Stock Exchange
Via ACCESSWIRE
News headline image
Ludwig Enterprises Developing New Partnerships to Fuel Growth
Via ACCESSWIRE
News headline image
Ludwig Enterprise mRNA Program Generating Broad Clinical Interest
Via ACCESSWIRE
News headline image
Ludwig Enterprises Announces Brand Name for Groundbreaking Nutraceutical
Via ACCESSWIRE
News headline image
Ludwig Enterprises Develops Program to Support Ketamine Clinics
Via ACCESSWIRE
News headline image
New Scientific Evidence Suggests How Chronic Illnesses May Be Prevented
Via ACCESSWIRE
News headline image
Ludwig Enterprises Launches Growth Plan
Via ACCESSWIRE
< Previous 1 2 Next >